Binding to serine 65‐phosphorylated ubiquitin primes Parkin for optimal PINK1‐dependent phosphorylation and activation. (26th June 2015)

• Record Type: Journal Article
• Authors: Kazlauskaite, Agne; Martínez‐Torres, R Julio; Wilkie, Scott; Kumar, Atul; Peltier, Julien; Gonzalez, Alba; Johnson, Clare; Zhang, Jinwei; Hope, Anthony G; Peggie, Mark; Trost, Matthias; van Aalten, Daan MF; Alessi, Dario R; Prescott, Alan R; Knebel, Axel; Walden, Helen; Muqit, Miratul MK
• Is Part Of: EMBO reports. Volume 16:Number 8(2015:Aug.)
• Page Start: 939
• Page End: 954
• Publication Date: 2015-06-26
• Subjects: Molecular biology -- Periodicals; Molecular Biology -- Periodicals; Molecular biology; Periodicals; 572.8
• DOI: 10.15252/embr.201540352
• Languages: English
• ISSNs: 1469-221X

Abstract

<abstract abstract-type="main" id="embr201540352-abs-0001"> <title>Abstract</title> <p>Mutations in the mitochondrial protein kinase PINK1 are associated with autosomal recessive Parkinson disease (PD). We and other groups have reported that PINK1 activates Parkin E3 ligase activity both directly via phosphorylation of Parkin serine 65 (Ser<sup>65</sup>)—which lies within its ubiquitin‐like domain (Ubl)—and indirectly through phosphorylation of ubiquitin at Ser<sup>65</sup>. How Ser<sup>65</sup>‐phosphorylated ubiquitin (ubiquitin<sup>Phospho‐Ser65</sup>) contributes to Parkin activation is currently unknown. Here, we demonstrate that ubiquitin<sup>Phospho‐Ser65</sup> binding to Parkin dramatically increases the rate and stoichiometry of Parkin phosphorylation at Ser<sup>65</sup> by PINK1 <italic>in vitro</italic>. Analysis of the Parkin structure, corroborated by site‐directed mutagenesis, shows that the conserved His302 and Lys151 residues play a critical role in binding of ubiquitin<sup>Phospho‐Ser65</sup>, thereby promoting Parkin Ser<sup>65</sup> phosphorylation and activation of its E3 ligase activity <italic>in vitro</italic>. Mutation of His302 markedly inhibits Parkin Ser<sup>65</sup> phosphorylation at the mitochondria, which is associated with a marked reduction in its E3 ligase activity following mitochondrial depolarisation. We show that the binding of ubiquitin<sup>Phospho‐Ser65</sup> to Parkin disrupts the interaction between the Ubl domain and C‐terminal region, thereby increasing the accessibility of Parkin Ser<sup>65</sup>. Finally, purified Parkin maximally phosphorylated at Ser<sup>65</sup><italic>in vitro</italic> cannot be further activated by the addition of ubiquitin<sup>Phospho‐Ser65</sup>. Our results thus suggest that a major role of ubiquitin<sup>Phospho‐Ser65</sup> is to promote PINK1‐mediated phosphorylation of Parkin at Ser<sup>65</sup>, leading to maximal activation of Parkin E3 ligase activity. His302 and Lys151 are likely to line a phospho‐Ser<sup>65</sup>‐binding pocket on the surface of Parkin that is critical for the ubiquitin<sup>Phospho‐Ser65</sup> interaction. This study provides new mechanistic insights into Parkin activation by ubiquitin<sup>Phospho‐Ser65</sup>, which could aid in the development of Parkin activators that mimic the effect of ubiquitin<sup>Phospho‐Ser65</sup>.</p> </abstract>